Tercica, Inc.
Records under this name other than patents Tercica, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Tercica, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,108,149 | Method and device for diagnosing and treating insulin-like growth factor deficiency disorders Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,258,864 | Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency Formerly held Term ended Term ended Aug 26, 2025 · USPTO record | Term ended | Term ended Aug 26, 2025 | USPTO record |
| US 8,133,862 | Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency Formerly held Term ended Term ended Mar 31, 2025 · USPTO record | Term ended | Term ended Mar 31, 2025 | USPTO record |
| US 7,517,530 | Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency comprising administration of IGF-1 and growth hormone Formerly held Term ended Ended no later than Sep 9, 2024 · USPTO record | Term ended | Ended no later than Sep 9, 2024 | USPTO record |
| US 8,158,582 | Methods for treatment of insulin-like growth factor-1 deficiency Formerly held Lapsed on the fee record Ended Apr 17, 2024 · USPTO record | Lapsed on the fee record | Ended Apr 17, 2024 | USPTO record |
| US 8,440,616 | Methods for treatment of insulin-like growth factor-1 deficiency Formerly held Lapsed on the fee record Ended May 14, 2021 · USPTO record | Lapsed on the fee record | Ended May 14, 2021 | USPTO record |
| US 7,833,964 | Methods of reducing visceral fat by increasing levels of insulin-like growth factor-I (IGF-I) Lapsed on the fee record Ended Nov 16, 2014 · USPTO record | Lapsed on the fee record | Ended Nov 16, 2014 | USPTO record |